{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:35Z","timestamp":1791928955718,"version":"4.3.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K22 CA2802019-01"],"award-info":[{"award-number":["K22 CA2802019-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017008","name":"Allen Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425-24-1-0119"],"award-info":[{"award-number":["HT9425-24-1-0119"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032703","name":"BridgeBio","doi-asserted-by":"publisher","award":["HT9425-23-1-0338"],"award-info":[{"award-number":["HT9425-23-1-0338"]}],"id":[{"id":"10.13039\/100032703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.omtm.2025.101556","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:19:40Z","timestamp":1755098380000},"page":"101556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7866-8030","authenticated-orcid":false,"given":"Edwina","family":"Abou Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L.","family":"Geffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Mahamdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomeh","family":"Tomeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Breyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Roumieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy J.","family":"Soberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Wojtkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Seungkyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xandra O.","family":"Breakefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101556_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.omtm.2025.101556_bib2","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.3928\/19382359-20170320-01","article-title":"Tuberous Sclerosis Complex: A Review","volume":"46","author":"Randle","year":"2017","journal-title":"Pediatr. Ann."},{"key":"10.1016\/j.omtm.2025.101556_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","article-title":"Evolving neurobiology of tuberous sclerosis complex","volume":"125","author":"Crino","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.omtm.2025.101556_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41380-023-02402-7","article-title":"The role of TSC1 and TSC2 proteins in neuronal axons","volume":"29","author":"Karalis","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.omtm.2025.101556_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.omtm.2025.101556_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1019343","article-title":"Spine morphogenesis and synapse formation in tubular sclerosis complex models","volume":"15","author":"Shimada","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1284394","article-title":"Loss of maturity and homeostatic functions in Tuberous Sclerosis Complex-derived astrocytes","volume":"17","author":"Luinenburg","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/nan.12744","article-title":"Impaired myelin production due to an intrinsic failure of oligodendrocytes in mTORpathies","volume":"47","author":"Gruber","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.omtm.2025.101556_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtm.2025.101556_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.omtm.2019.08.003","article-title":"Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1","volume":"15","author":"Prabhakar","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101556_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","article-title":"Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin","volume":"45","author":"Carson","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtm.2025.101556_bib12","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1093\/hmg\/ddr393","article-title":"Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex","volume":"20","author":"Anderl","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101556_bib13","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijdevneu.2013.02.008","article-title":"A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits","volume":"31","author":"Feliciano","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067680","article-title":"Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain","volume":"8","author":"Chakrabarty","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101556_bib16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","article-title":"Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions","volume":"9","author":"Magri","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omtm.2025.101556_bib17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","article-title":"Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse","volume":"18","author":"Way","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101556_bib18","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","article-title":"Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2","volume":"8","author":"Tavazoie","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib19","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1038\/srep05506","article-title":"Targeted gene transfer into ependymal cells through intraventricular injection of AAV1 vector and long-term enzyme replacement via the CSF","volume":"4","author":"Yamazaki","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101556_bib20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.16750211","article-title":"Tsc1 mutant neural stem\/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle","volume":"25","author":"Zhou","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.omtm.2025.101556_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1365-2990.2007.00890.x","article-title":"Microglial activation in white matter lesions and nonlesional white matter of ageing brains","volume":"33","author":"Simpson","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.omtm.2025.101556_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.omtm.2025.101556_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2025.101556_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1097-4547(19991101)58:3<387::AID-JNR4>3.0.CO;2-L","article-title":"Mannose receptor is present in a functional state in rat microglial cells","volume":"58","author":"Marzolo","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.omtm.2025.101556_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/glia.22298","article-title":"Comparison of polarization properties of human adult microglia and blood-derived macrophages","volume":"60","author":"Durafourt","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.omtm.2025.101556_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1098-1136(19990101)25:1<44::AID-GLIA5>3.0.CO;2-C","article-title":"Identification and functional characterization of the mannose receptor in astrocytes","volume":"25","author":"Burudi","year":"1999","journal-title":"Glia"},{"key":"10.1016\/j.omtm.2025.101556_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0074-7696(03)01006-4","article-title":"The mannose receptor in the brain","volume":"226","author":"Regnier-Vigouroux","year":"2003","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.omtm.2025.101556_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.54","article-title":"Minocycline selectively inhibits M1 polarization of microglia","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtm.2025.101556_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","article-title":"Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro","volume":"32","author":"Chhor","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.omtm.2025.101556_bib30","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1750-3639.2010.00416.x","article-title":"Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events","volume":"20","author":"Qin","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.omtm.2025.101556_bib31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101556_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.spen.2006.01.009","article-title":"The neurobiology of tuberous sclerosis complex","volume":"13","author":"Ess","year":"2006","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.omtm.2025.101556_bib33","doi-asserted-by":"crossref","first-page":"7368","DOI":"10.1523\/JNEUROSCI.5746-12.2013","article-title":"Modeling transformations of neurodevelopmental sequences across mammalian species","volume":"33","author":"Workman","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omtm.2025.101556_bib35","doi-asserted-by":"crossref","first-page":"E1070","DOI":"10.1073\/pnas.1106454108","article-title":"Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex","volume":"108","author":"Goto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101556_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123241","article-title":"The Evolving Landscape of Therapeutics for Epilepsy in Tuberous Sclerosis Complex","volume":"11","author":"Vitale","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtm.2025.101556_bib37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s40263-022-00955-9","article-title":"Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies","volume":"36","author":"Strzelczyk","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.omtm.2025.101556_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.105898","article-title":"A phase II clinical trial of the Safety Of Simvastatin (SOS) in patients with pulmonary lymphangioleiomyomatosis and with tuberous sclerosis complex","volume":"163","author":"Krymskaya","year":"2020","journal-title":"Respir. Med."},{"key":"10.1016\/j.omtm.2025.101556_bib39","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"mTOR signaling, Tregs and immune modulation","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.omtm.2025.101556_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12031-016-0872-y","article-title":"Brain Development and Akt Signaling: the Crossroads of Signaling Pathway and Neurodevelopmental Diseases","volume":"61","author":"Wang","year":"2017","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021050","article-title":"Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders","volume":"25","author":"Daci","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101556_bib42","doi-asserted-by":"crossref","first-page":"8S46","DOI":"10.1016\/S0929-693X(23)00227-0","article-title":"Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors","volume":"30","author":"Gardin","year":"2023","journal-title":"Arch. Pediatr."},{"key":"10.1016\/j.omtm.2025.101556_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101168","article-title":"Intrathecal delivery of a bicistronic AAV9 vector expressing beta-hexosaminidase A corrects Sandhoff disease in a murine model: A dosage study","volume":"32","author":"Ryckman","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101556_bib44","article-title":"Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome","volume":"34","author":"Laoharawee","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omtm.2025.101556_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101556_bib46","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/ar.1091200104","article-title":"Equivalent ages in mouse and human embryos","volume":"120","author":"Otis","year":"1954","journal-title":"Anat. Rec."},{"key":"10.1016\/j.omtm.2025.101556_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/neup.13013","article-title":"Solitary subependymal giant cell astrocytoma lacking TSC1\/2 mutations and TTF-1 expression: A potential diagnostic pitfall","volume":"45","author":"Mulone","year":"2025","journal-title":"Neuropathology"},{"key":"10.1016\/j.omtm.2025.101556_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1148\/radiology.183.1.1549677","article-title":"MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review","volume":"183","author":"Braffman","year":"1992","journal-title":"Radiology"},{"key":"10.1016\/j.omtm.2025.101556_bib49","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3174\/ajnr.A0642","article-title":"Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex","volume":"28","author":"Makki","year":"2007","journal-title":"AJNR. Am. J. Neuroradiol."},{"key":"10.1016\/j.omtm.2025.101556_bib50","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/02841859809172211","article-title":"White matter abnormalities in tuberous sclerosis complex","volume":"39","author":"Griffiths","year":"1998","journal-title":"Acta Radiol."},{"key":"10.1016\/j.omtm.2025.101556_bib51","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3390\/cimb45050254","article-title":"Specific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex","volume":"45","author":"Bychkova","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.omtm.2025.101556_bib52","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnen\/nlaa090","article-title":"Myelin Pathology Beyond White Matter in Tuberous Sclerosis Complex (TSC) Cortical Tubers","volume":"79","author":"Muhlebner","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtm.2025.101556_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2008.06.073","article-title":"Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex","volume":"156","author":"Boer","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.omtm.2025.101556_bib54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S0033291701004561","article-title":"Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis","volume":"31","author":"Ridler","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.omtm.2025.101556_bib55","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00247-005-1539-y","article-title":"Magnetization transfer ratio measurements of the brain in children with tuberous sclerosis complex","volume":"35","author":"Zikou","year":"2005","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.omtm.2025.101556_bib56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/hmg\/ddq491","article-title":"Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex","volume":"20","author":"Zeng","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2025.101556_bib57","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib58","doi-asserted-by":"crossref","first-page":"8432","DOI":"10.1523\/JNEUROSCI.1105-14.2014","article-title":"Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination","volume":"34","author":"Lebrun-Julien","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtm.2025.101556_bib59","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101556_bib60","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.4049\/jimmunol.1303492","article-title":"mTOR signaling inhibition modulates macrophage\/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia","volume":"192","author":"Xie","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101556_bib61","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1096\/fj.201600495R","article-title":"mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type","volume":"30","author":"Li","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2025.101556_bib62","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/epi.16824","article-title":"A hypothesis for the role of axon demyelination in seizure generation","volume":"62","author":"de Curtis","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.omtm.2025.101556_bib63","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1242\/jcs.151043","article-title":"Myelination at a glance","volume":"127","author":"Snaidero","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omtm.2025.101556_bib64","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1073\/pnas.96.9.5037","article-title":"Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice","volume":"96","author":"Mao","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101556_bib65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1538\/expanim.20-0186","article-title":"AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice","volume":"70","author":"Prabhakar","year":"2021","journal-title":"Exp. Anim."}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125001512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T17:07:29Z","timestamp":1772903249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125001512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2329050125001512"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101556","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101556"}}